A Case of Deep Venous Thrombosis in an HIV-Infected Patient despite Therapeutic Anticoagulation
- PMID: 38868809
- PMCID: PMC11166488
- DOI: 10.18502/ijhoscr.v18i2.15379
A Case of Deep Venous Thrombosis in an HIV-Infected Patient despite Therapeutic Anticoagulation
Abstract
Patients with human immunodeficiency virus (HIV) infection have an increased likelihood of venous thromboembolism (VTE) owing to factors such as acquired protein C and S deficiency, antiphospholipid antibody syndrome, and heightened levels of pro-inflammatory cytokines. This case report highlights an exceptionally uncommon occurrence of deep venous thrombosis in an HIV-infected patient receiving a therapeutic dose of enoxaparin. This underscores the need for cautious consideration of the risk of VTE in HIV-infected individuals, even with preventive or therapeutic anticoagulant treatment. Further research is recommended to investigate HIV as a potential risk factor of prophylactic anticoagulation.
Keywords: Anti-coagulants; Deep venous thrombosis; Enoxaparin; Human immunodeficiency virus (HIV).
Copyright © 2024 Tehran University of Medical Sciences.
Conflict of interest statement
All authors declare no conflict of interest.
References
-
- Oliveira R, Patel RK, Taylor C, et al. Direct oral anticoagulants for the management of venous thromboembolism in patients with HIV - a single centre experience. Br J Haematol. 2019;186(5):e148–e151. - PubMed
-
- Erbe M, Rickerts V, Bauersachs RM, et al. Acquired protein C and protein S deficiency in HIV-infected patients. Clin Appl Thromb Hemost. 2003;9(4):325–31. - PubMed
Publication types
LinkOut - more resources
Full Text Sources